eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0006 (300.00%)
At close: Oct 22, 2026
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $3.76 thousand as of October 23, 2026. It is the 52,158th most valuable company in the world and the 8,117th biggest in the United States. Its market cap has increased by 300.00% in one year.
Market Cap
3.76K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,117 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 3.76K, a decrease of -100.00%. That is a compound annual growth rate of -85.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.76K | 300.00% |
| Dec 31, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MultiCell Technologies | 5.00K |
| Arno Therapeutics | 4.98K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| MetaStat | 4.11K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |